NSE · AI Signal & Stock Analysis · Neutral
As of Nov 13 2026, 6:15 AM, AkshayaAI's signal for ANTHEM is Neutral → (strong move); technical trend raise-2026-11-04; trading at ₹938.45 (-1.99% today); neutral (RSI 66). AkshayaAI's signal, trend and forecast for ANTHEM have been unchanged since 5 Nov 2026.
Data as of Nov 13 2026, 6:15 AM. Informational analytics only — not investment advice.
Instant, data-backed answers — free to try.
| AI signal | Neutral → · Strong move |
|---|---|
| Technical trend | RAISE-2026-11-04 |
| Price | ₹938.45 |
| Change today | -1.99% |
| RSI (14) | 66.50 |
| Relative volume | 0.50 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | ₹52,800 Cr |
| P/E | 86.59 |
| Cap category | Large Cap |
| 52-week high | -2.1% away |
| 52-week low | +58.8% above |
| Delivery volume | — |
| Sector | Biotechnology |
As of Nov 13 2026, 6:15 AM, AkshayaAI's signal for ANTHEM (Anthem Biosciences Limited) is Neutral with a strong move, and its technical trend is raise-2026-11-04. The composite score and full factor breakdown are available to signed-in members.
ANTHEM's RSI is neutral (RSI 66). A reading above 70 is typically overbought and below 30 oversold.
ANTHEM is trading about 2% below its 52-week high and 59% above its 52-week low as of Nov 13 2026, 6:15 AM.
ANTHEM's market capitalisation is ₹52,800 Cr as of Nov 13 2026, 6:15 AM.
ANTHEM is classified under Biotechnology in AkshayaAI's taxonomy.
AkshayaAI refreshes its signals daily. The figures on this page are timestamped as of the latest run shown above.
No. AkshayaAI provides informational, AI-generated analytics for ANTHEM — not personalised investment advice. Always do your own research.
BIOCON · BLUEJET · CONCORDBIO · ONESOURCE · SUPRIYA
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Nov 13 2026, 6:15 AM and may not reflect real-time prices. Always do your own research. How these signals work →